Skip to main content

Table 1 Relationship between miR-638 expression and their clinic-pathological characteristics of breast cancer patients

From: MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt/β-cadherin pathway

Characteristics

Cases

miR-638

P value

High

Low

Age (years)

   

0.11

 ≥ 50

27

12

15

 

 < 50

25

10

15

 

Tumor size

   

0.022*

 < 3 cm

35

11

24

 

 ≥ 3 cm

17

5

12

 

ER status

   

0.256

 Negative

22

8

14

 

 Positive

30

13

17

 

PR status

   

0.119

 Negative

24

10

14

 

 Positive

28

13

15

 

HER2 status

   

0.391

 Negative

32

14

18

 

 Positive

20

7

13

 

Lymph node metastasis

   

0.004*

 Yes

37

12

25

 

 No

15

5

10

 

TNM stage

   

0.049*

 I-II

14

6

8

 

 III-IV

38

15

23

 
  1. Statistical analyses were performed by the χ2 test
  2. *P < 0.05 was considered significant